Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.
about
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal BlockageCoupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated ImmunityDendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles.The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent MechanismDissecting the dendritic cell controversy in chronic hepatitis B virus infection.Modulatory effects on dendritic cells by human herpesvirus 6.Application of antigen cross-presentation research into patient care.Efferocytosis of Pathogen-Infected Cells.Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death.Comparison of morphology, phenotypes and function between cultured human IL‑4‑DC and IFN‑DC.HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo.Pathogen recognition by NK cells amplifies the pro-inflammatory cytokine production of monocyte-derived DC via IFN-γ.
P2860
Q26778646-A26B3379-8A95-4213-BF13-6D74F9C3BD7DQ28603015-8E324942-5570-4A59-9A7B-7345588895E8Q36098858-0ECBACBD-22B7-40EF-986E-DF0707FAEF5BQ36104804-43BE3B85-E9C3-45FA-A088-A97432FE490FQ37073307-1F378D05-01DC-4CD8-9B40-3FBAE5879A74Q38264371-4F757FB7-7281-470C-9A5C-0AB339D847CCQ38487111-AB14B139-722D-4881-A613-F540F880A0B5Q40792261-68AF374F-0B3C-4193-9DDA-6212922535E3Q47171468-0265FBDC-CBAD-49F4-A923-DB2E26F3520CQ47569692-373E800B-105F-422C-9F33-7F2794B80EC0Q47749291-672D8F41-1E65-452C-928E-604FACE82230Q48576315-21FD5472-7E2A-4E91-90CC-8E31D9193962Q49265074-0CE4D9F0-E851-4885-B57F-545BB58B8B9D
P2860
Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding MHC class I pres ...... esign of therapeutic vaccines.
@en
type
label
Understanding MHC class I pres ...... esign of therapeutic vaccines.
@en
prefLabel
Understanding MHC class I pres ...... esign of therapeutic vaccines.
@en
P2093
P2860
P356
P1476
Understanding MHC class I pres ...... esign of therapeutic vaccines.
@en
P2093
Andrea M Woltman
Evelyn van der Aa
Nadine van Montfoort
P2860
P356
10.3389/FIMMU.2014.00182
P577
2014-04-23T00:00:00Z